ArticleCancers2021

Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results.

Jermaine I Coward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.